ArticleHepatology (Baltimore, Md.)2014

Cost analysis of sofosbuvir/ribavirin versus sofosbuvir/simeprevir for genotype 1 hepatitis C virus in interferon-ineligible/intolerant individuals.

Liesl M Hagan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.